CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 58 enrolled
Drug / intervention
r-FSH +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01112358
NCT01112358Phase 2Completed
CompareCT.gov

Lutropin Alfa (Luveris®) in Women at Risk of Poor Response Suppressed With Cetrorelix: an Exploratory Trial

Merck KGaA, Darmstadt, Germany·interventional·Posted Apr 28, 2010·Updated Aug 28, 2018

In Brief

A Phase 2 clinical trial evaluating r-FSH, r-hLH, and 3 other interventions for Ovarian Stimulation. Completed, enrolled 58 participants across 1 site.

Detailed Summary

Evaluate the effectiveness of adding lutropin alfa (recombinant human luteinizing hormone \[r-hLH\]) in the middle of the follicular phase compared to no addition, in infertile women at risk of poor response stimulated with follitropin alfa (recombinant Follicle-Stimulating Hormone \[r-FSH\]) under Gonadotropin Releasing Hormone (GnRH) antagonist in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI), in the number and quality of oocytes, follicular development, fertilization oocyte, embryo quality, and pregnancy rate.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOvarian Stimulation
CountriesSpain
Collaborators--

Timeline

Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 28, 2010
Enrollment StartDec 7, 2005
Primary CompletionJan 30, 2007
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 16.2 years ago

Interventions

r-FSHdrug

r-FSH will be administered as specified in the arm description.

r-hLHdrug

r-hLH will be administered as specified in the arm description.

Analogous GnRH antagonistdrug

Analogous GnRH antagonist will be administered as specified in the arm description.

r-hCGdrug

r-hCG will be administered as specified in the arm description.

Progesteronedrug

Progesterone will be administered as specified in the arm description.